Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants.
about
Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo).Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.Vancomycin monitoring in children using bayesian estimation.Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysisLimited sampling strategy of partial area under the concentration-time curves to estimate midazolam systemic clearance for cytochrome P450 3A phenotyping.Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.Evaluation of limited sampling strategies for tacrolimus.Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review.Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?Limited-sampling strategies for anti-infective agents: systematic review.Importance of pharmacokinetics in the management of hemophilia.Clinical mycophenolic acid monitoring in liver transplant recipients.Clinical pharmacy service practice in a Chinese tertiary hospital.Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Impact of sampling time deviations on the prediction of the area under the curve using regression limited sampling strategies.The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A.Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients.Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies.Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children.Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients.Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients.Cyclosporin A-induced gingival overgrowth is not associated with myofibroblast transdifferentiation.
P2860
Q31147438-DAEAD9B9-D6D0-42B5-984B-B3AF301ACDB7Q33888004-533C1A60-C031-4F9B-B911-1803D4C087ECQ33911485-3DD41234-3F3D-4CDF-A9A2-4141A830FBADQ34580586-10CA5034-5647-45E3-B2DE-0330A7CB56B3Q34596844-2E9C204C-EFBB-40B9-8A90-95D6AFD9821DQ34810573-321E8954-AC24-4248-93DD-BEBE6F31641FQ35681653-AAAD5049-5DED-48A3-8125-5D6AB0657E73Q35729869-65C8D10D-B086-454A-9D31-CE82FA5E727EQ35859862-3DCD6EB7-7415-4531-A121-5F07E3F4F0C3Q36087599-5C9F57B8-5CCE-4B65-BEE6-582BAEEAC001Q36730079-F76A27F6-13C9-44CE-B8A4-09BE3585458FQ36788423-1C09E290-75BB-436F-9D73-B6C752B51BFBQ37506535-64CB678C-9CDA-4A19-8D31-F7BB208D6972Q37581617-46E3CAC1-FDD7-47B8-BA9C-77F903073E0EQ37956717-549AD925-2A81-4E7F-AF39-03E2AA536BADQ38000241-EEDD05C2-1BD2-4F5E-8923-132F0F1CF954Q38056463-0482E00A-6864-4FB0-9068-C55AFE4EE6F6Q38242804-8DDA4E10-A0E4-4A6B-9E92-E80FEF9177DEQ38604859-5CABE5D9-F829-4BED-83DD-598378193896Q38809767-8873DEA0-0AA6-40A0-98F0-F2A4EFA40F42Q39021313-2A24A98B-356D-4B3C-9433-71D60A6CE747Q39475869-823A5E99-C285-4DE0-BD03-1B7E73B3AEAAQ42597049-D8360ACD-0F11-4806-885E-D2AAAF823FD9Q43227279-BB28E6E3-932B-4333-964D-ED3DBFD04FE7Q43654216-E5276207-850A-4A0E-85FC-8A3EB4318000Q44998438-C4415080-8933-4511-8BA1-2B895C58D4F2Q45985298-3DFEB9FC-44EA-4017-821A-0D2D27308B1EQ46121158-8BFDF094-5E86-430B-AEFD-79DD328117B7Q48559800-975A3E2F-329A-4E39-BA4E-F5795F4268BDQ51559938-3404F5A6-C545-46DB-B115-212EFBC7D26EQ51595257-F3C73B26-777B-4E9F-ABB9-E2E082C6616CQ53093650-5966175D-B076-4059-8B7C-DA11E283F1B4Q54418414-69B136D5-873D-405F-8640-F35DE39BA662
P2860
Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@ast
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@en
type
label
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@ast
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@en
prefLabel
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@ast
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@en
P2093
P1476
Beyond cyclosporine: a systema ...... for other immunosuppressants.
@en
P2093
Eric Villeneuve
Lillian S L Ting
Mary H H Ensom
P304
P356
10.1097/01.FTD.0000211810.19935.44
P577
2006-06-01T00:00:00Z